VOR Sense

VorSense is an Israeli biotechnology company developing a high-sensitivity, single-molecule sensing platform based on nanopore technology. Spun out from the Technion – Israel Institute of Technology, the company's technology enables the direct electrical detection of DNA, RNA, and proteins without the need for amplification or complex labeling. This platform is designed for applications in early cancer detection, infectious disease diagnostics, and personalized medicine. By providing rapid and precise molecular analysis, VorSense aims to transform the landscape of point-of-care diagnostics and clinical research. The company's approach offers a significant advantage in speed and sensitivity compared to traditional diagnostic methods, targeting the growing need for rapid, laboratory-grade results in point-of-care settings.